Edward J Dulac III insider trades

Open-market stock purchases and sales by Edward J Dulac III, EVP, Chief Financial Officer at Intellia Therapeutics, Inc, from SEC Form 4 filings since Aug 17, 2020.

Recent trades

DateStockTradeValue
Jul 22, 2026NTLA Intellia Therapeutics, IncSold$91.2K
Jul 2, 2026NTLA Intellia Therapeutics, IncSold$84.2K
Mar 1, 2026NTLA Intellia Therapeutics, IncBought (not open market)—
Mar 1, 2026NTLA Intellia Therapeutics, IncBought (not open market)—
Jan 5, 2026NTLA Intellia Therapeutics, IncSold$58.8K

Companies traded

  • NTLA Intellia Therapeutics, Inc: 4 sales, last Jul 22, 2026
  • FATE Fate Therapeutics Inc: 17 sales, last Mar 4, 2024

Get free alerts when Edward J Dulac III files a new trade →